Quick access to helpful in-office professional and patient resources

Select option 1 for BENLYSTA Gateway

1-877-4-BENLYSTA (1-877-423-6597)

Monday-Friday, 8 AM to 8 PM, ET

1-877-4-BENLYSTA (1-877-423-6597)

Select option 1 for BENLYSTA Gateway

Monday-Friday, 8 AM to 8 PM, ET

BENLYSTA Gateway Enrollment Form

A form to register for BENLYSTA Gateway.

English language Spanish language

Considering BENLYSTA IV for Patients

Read facts about BENLYSTA, ambassador stories sharing their experience with BENLYSTA and frequently asked questions about BENLYSTA.

English language

BENLYSTA Patient Brochure

A brochure highlighting information on BENLYSTA IV and SC. Provides patients questions to ask about BENLYSTA at their appointments.

English language

Getting Started on IV for Patients

Details the infusion process and answers commonly asked patient questions. Provides post-infusion tips and shares other patients' experiences with BENLYSTA infusions.

English language

Patient Communication Journal for IV

Journal to provide patients a space where they can write down their thoughts, questions, concerns and keep track of their day-to-day experiences. Patients are encouraged to share this booklet with their doctor.

English language Spanish language Chinese language

Patient Diary for SC

A diary for patients to document details on their injections and questions for their doctor.

English language Only

Co-pay and Coverage Resources for Patients

Information on insurance coverage and co-pay assistance for eligible patients who are considering BENLYSTA.

English language

BENLYSTA Cares Overview for Patients

Guide outlining BENLYSTA Cares program, co-pay and coverage information, supplemental injection support, other information and tools available to patients.

English language Only

BENLYSTA SC Instructions for Use for Patients

English language

Find the vial combination that helps minimize product waste.

Calculate patients' infusion dates.

Additional practical dosing information and tools can be found on the Dosing & Administration page.

Brochures and forms for accessing BENLYSTA are available on the Access & Support page.

Helpful tools to identify patients appropriate for BENLYSTA are found on the Identifying Patients page.

Videos and brochures review the pivotal trials on the Efficacy page.

e-Lecture video series about SLE and BENLYSTA

Five informative videos have been developed that detail SLE and its treatment with BENLYSTA.

They are also found throughout this site.

Watch Clinical Trials:

Efficacy and Safety of BENLYSTA

Gain an understanding of the BLISS IV clinical trials supporting the efficacy and safety of BENLYSTA.

Watch BENLYSTA for

the Treatment of SLE

Discover information on the mechanism of action of BENLYSTA and the clinical trials supporting the efficacy and safety of BENLYSTA.

Watch Recognizing

Active SLE Disease

Get an overview of several assessment tools for measuring disease activity, including SELENA-SLEDAI, BILAG, and PGA.

Watch Dosing and

Administration of BENLYSTA

Learn about how BENLYSTA is supplied, use of the vial calculator and instructions for the reconstitution and dilution processes for the intravenous formulation.

Watch SLE


Refresh your knowledge of B-cell development, the role of BLyS in SLE, and the mechanism of action of BENLYSTA.


Mechanism of Action


Explore how BENLYSTA works in patients with SLE, and how targeting BLyS can help reduce disease activity.

Meet the Experts

Jennifer Sloan, MD

Dr. Sloane is a Medical Director for Immuno-inflammation in US Medical Affairs at GSK. She is board certified in internal medicine and rheumatology.

Prior to joining GSK in 2015, Dr. Sloane held faculty positions at Temple University and Thomas Jefferson University. In addition to seeing patients, Dr. Sloane was a rheumatology fellowship director. She was also involved in several projects focusing on rheumatology education.

Dr. Sloane received her medical degree from Albert Einstein College of Medicine of Yeshiva University and completed her residency in internal medicine and fellowship in rheumatology at New York University Medical Center.

William Eastman, MD

Dr. Eastman is a Medical Director and US Medical Affairs Lead for the Immuno-inflammation Therapeutic Area at GSK. In this role, Dr. Eastman oversees US medical support for systemic lupus erythematosus (SLE) assets at GSK. He previously served as Medical Director, US Medical Affairs Lead for the dermatology therapeutic area at GSK.

Dr. Eastman received his medical degree from East Carolina University School of Medicine, where he was a Brody Scholar. He trained in internal medicine at Duke University Medical Center.

Dr. Eastman has 22 years of pharmaceutical industry experience, with leadership roles in medical affairs, pharmacovigilance, clinical project management, medical writing, and data management.

Tania González-Rivera, MD

Tania González-Rivera joined GSK in 2016 as an Immuno-inflammation Medical Director. Tania is certified by the American Board of Internal Medicine and Rheumatology.

Dr. Gonzalez-Rivera is a rheumatologist who specializes in lupus and was an investigator for several lupus clinical trials. Prior to joining GSK, Tania held faculty positions at the University of Pennsylvania and the University of Michigan. She continues to be involved in patient care at the Corporal Michael J. Crescenz Veteran’s Affairs Medical Center in Philadelphia, PA twice a month.

She received her medical degree and completed her residency in Internal Medicine at the University of Puerto Rico and a fellowship in Rheumatology at the University of Michigan Health System.

1003629R0 April 2018